Janux raises $56M to take safer T-cell engagers into the clinic

Janux raises $56M to take safer T-cell engagers into the clinic

Submitted by admin on March 4, 2021 - 9:54am
Source: 
Fierce Biotech
News Tags: 
Janux Therapeutics
T-cell engager
Headline: 
Janux raises $56M to take safer T-cell engagers into the clinic
snippet: 

Janux Therapeutics has raised $56 million to fund development of T-cell engagers (TCEs). The series A will fund preclinical work on TROP-2 and PSMA candidates, positioning Janux to enter the clinic next year.

Do Not Allow Advertisers to Use My Personal information